Human Vaccine Industry Research Report 2024
This report aims to provide a comprehensive presentation of the global market for Human Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccine.
The Human Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Human Vaccine type, along with growth forecasts through 2030. Estimates on sales and revenue are based on the price in the supply chain at which the Human Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Human Vaccine segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Human Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Human Vaccine market.
Human Vaccine segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Human Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Human Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Human Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Vaccine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
The Human Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- CNBG
- Changsheng Life
- Zhifei
- ChengDa Bio
- Kangtai
- SINOVAC BIOTECH
- Hissen
- Walvax Biotechnology
- GSK
- SANOFI
- Rong An
- NuoCheng Bio
- Hualan Bio
- Tiantan biological
- Changchun Baike
- Adimmune
- Zhongyianke Biotech
- Bharat Biotech
- Bavarian Nordic
- Sanofi-Pasteur
- Indian Immunologicals
- KANGH
- Henan Grand Biopharma
- ZhongKe Biopharm
- Zhuoyi Biological
Global markets are presented by Human Vaccine type, along with growth forecasts through 2030. Estimates on sales and revenue are based on the price in the supply chain at which the Human Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Human Vaccine segment by Type
- Varicella
- Influenza
- Polio
- Hepatitis A
- Rabies
- BCG
- Hepatitis B
- Pertussis, Diphtheria, Tetanus
- Pneumococcal
- Rota vaccine
This report has provided the market size (sales and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Human Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Human Vaccine market.
Human Vaccine segment by Application
- Adults
- Children
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Human Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Human Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Human Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Vaccine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Human Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Human Vaccine Sales (2019-2030)
2.2.3 Global Human Vaccine Market Average Price (2019-2030)
2.3 Human Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
2.4 Human Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Adults
2.4.3 Children
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Human Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Human Vaccine Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Human Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Human Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Human Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Human Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Human Vaccine, Product Type & Application
3.8 Global Manufacturers of Human Vaccine, Date of Enter into This Industry
3.9 Global Human Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 CNBG
4.1.1 CNBG Company Information
4.1.2 CNBG Business Overview
4.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 CNBG Human Vaccine Product Portfolio
4.1.5 CNBG Recent Developments
4.2 Changsheng Life
4.2.1 Changsheng Life Company Information
4.2.2 Changsheng Life Business Overview
4.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Changsheng Life Human Vaccine Product Portfolio
4.2.5 Changsheng Life Recent Developments
4.3 Zhifei
4.3.1 Zhifei Company Information
4.3.2 Zhifei Business Overview
4.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Zhifei Human Vaccine Product Portfolio
4.3.5 Zhifei Recent Developments
4.4 ChengDa Bio
4.4.1 ChengDa Bio Company Information
4.4.2 ChengDa Bio Business Overview
4.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 ChengDa Bio Human Vaccine Product Portfolio
4.4.5 ChengDa Bio Recent Developments
4.5 Kangtai
4.5.1 Kangtai Company Information
4.5.2 Kangtai Business Overview
4.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Kangtai Human Vaccine Product Portfolio
4.5.5 Kangtai Recent Developments
4.6 SINOVAC BIOTECH
4.6.1 SINOVAC BIOTECH Company Information
4.6.2 SINOVAC BIOTECH Business Overview
4.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 SINOVAC BIOTECH Human Vaccine Product Portfolio
4.6.5 SINOVAC BIOTECH Recent Developments
4.7 Hissen
4.7.1 Hissen Company Information
4.7.2 Hissen Business Overview
4.7.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Hissen Human Vaccine Product Portfolio
4.7.5 Hissen Recent Developments
4.8 Walvax Biotechnology
4.8.1 Walvax Biotechnology Company Information
4.8.2 Walvax Biotechnology Business Overview
4.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Walvax Biotechnology Human Vaccine Product Portfolio
4.8.5 Walvax Biotechnology Recent Developments
4.9 GSK
4.9.1 GSK Company Information
4.9.2 GSK Business Overview
4.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.9.4 GSK Human Vaccine Product Portfolio
4.9.5 GSK Recent Developments
4.10 SANOFI
4.10.1 SANOFI Company Information
4.10.2 SANOFI Business Overview
4.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.10.4 SANOFI Human Vaccine Product Portfolio
4.10.5 SANOFI Recent Developments
6.11 Rong An
6.11.1 Rong An Company Information
6.11.2 Rong An Human Vaccine Business Overview
6.11.3 Rong An Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Rong An Human Vaccine Product Portfolio
6.11.5 Rong An Recent Developments
6.12 NuoCheng Bio
6.12.1 NuoCheng Bio Company Information
6.12.2 NuoCheng Bio Human Vaccine Business Overview
6.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 NuoCheng Bio Human Vaccine Product Portfolio
6.12.5 NuoCheng Bio Recent Developments
6.13 Hualan Bio
6.13.1 Hualan Bio Company Information
6.13.2 Hualan Bio Human Vaccine Business Overview
6.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hualan Bio Human Vaccine Product Portfolio
6.13.5 Hualan Bio Recent Developments
6.14 Tiantan biological
6.14.1 Tiantan biological Company Information
6.14.2 Tiantan biological Human Vaccine Business Overview
6.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Tiantan biological Human Vaccine Product Portfolio
6.14.5 Tiantan biological Recent Developments
6.15 Changchun Baike
6.15.1 Changchun Baike Company Information
6.15.2 Changchun Baike Human Vaccine Business Overview
6.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Changchun Baike Human Vaccine Product Portfolio
6.15.5 Changchun Baike Recent Developments
6.16 Adimmune
6.16.1 Adimmune Company Information
6.16.2 Adimmune Human Vaccine Business Overview
6.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Adimmune Human Vaccine Product Portfolio
6.16.5 Adimmune Recent Developments
6.17 Zhongyianke Biotech
6.17.1 Zhongyianke Biotech Company Information
6.17.2 Zhongyianke Biotech Human Vaccine Business Overview
6.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Zhongyianke Biotech Human Vaccine Product Portfolio
6.17.5 Zhongyianke Biotech Recent Developments
6.18 Bharat Biotech
6.18.1 Bharat Biotech Company Information
6.18.2 Bharat Biotech Human Vaccine Business Overview
6.18.3 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Bharat Biotech Human Vaccine Product Portfolio
6.18.5 Bharat Biotech Recent Developments
6.19 Bavarian Nordic
6.19.1 Bavarian Nordic Company Information
6.19.2 Bavarian Nordic Human Vaccine Business Overview
6.19.3 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Bavarian Nordic Human Vaccine Product Portfolio
6.19.5 Bavarian Nordic Recent Developments
6.20 Sanofi-Pasteur
6.20.1 Sanofi-Pasteur Company Information
6.20.2 Sanofi-Pasteur Human Vaccine Business Overview
6.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Sanofi-Pasteur Human Vaccine Product Portfolio
6.20.5 Sanofi-Pasteur Recent Developments
6.21 Indian Immunologicals
6.21.1 Indian Immunologicals Company Information
6.21.2 Indian Immunologicals Human Vaccine Business Overview
6.21.3 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Indian Immunologicals Human Vaccine Product Portfolio
6.21.5 Indian Immunologicals Recent Developments
6.22 KANGH
6.22.1 KANGH Company Information
6.22.2 KANGH Human Vaccine Business Overview
6.22.3 KANGH Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.22.4 KANGH Human Vaccine Product Portfolio
6.22.5 KANGH Recent Developments
6.23 Henan Grand Biopharma
6.23.1 Henan Grand Biopharma Company Information
6.23.2 Henan Grand Biopharma Human Vaccine Business Overview
6.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Henan Grand Biopharma Human Vaccine Product Portfolio
6.23.5 Henan Grand Biopharma Recent Developments
6.24 ZhongKe Biopharm
6.24.1 ZhongKe Biopharm Company Information
6.24.2 ZhongKe Biopharm Human Vaccine Business Overview
6.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.24.4 ZhongKe Biopharm Human Vaccine Product Portfolio
6.24.5 ZhongKe Biopharm Recent Developments
6.25 Zhuoyi Biological
6.25.1 Zhuoyi Biological Company Information
6.25.2 Zhuoyi Biological Human Vaccine Business Overview
6.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Zhuoyi Biological Human Vaccine Product Portfolio
6.25.5 Zhuoyi Biological Recent Developments
5 GLOBAL HUMAN VACCINE MARKET SCENARIO BY REGION
5.1 Global Human Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Human Vaccine Sales by Region: 2019-2030
5.2.1 Global Human Vaccine Sales by Region: 2019-2024
5.2.2 Global Human Vaccine Sales by Region: 2025-2030
5.3 Global Human Vaccine Revenue by Region: 2019-2030
5.3.1 Global Human Vaccine Revenue by Region: 2019-2024
5.3.2 Global Human Vaccine Revenue by Region: 2025-2030
5.4 North America Human Vaccine Market Facts & Figures by Country
5.4.1 North America Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Human Vaccine Sales by Country (2019-2030)
5.4.3 North America Human Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Human Vaccine Market Facts & Figures by Country
5.5.1 Europe Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Human Vaccine Sales by Country (2019-2030)
5.5.3 Europe Human Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Human Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Human Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Human Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Human Vaccine Market Facts & Figures by Country
5.7.1 Latin America Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Human Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Human Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Human Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Human Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Human Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Human Vaccine Sales by Type (2019-2030)
6.1.1 Global Human Vaccine Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Human Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Human Vaccine Revenue by Type (2019-2030)
6.2.1 Global Human Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Human Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Human Vaccine Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Human Vaccine Sales by Application (2019-2030)
7.1.1 Global Human Vaccine Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Human Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Human Vaccine Revenue by Application (2019-2030)
6.2.1 Global Human Vaccine Sales by Application (2019-2030) & (US$ Million)
6.2.2 Global Human Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Human Vaccine Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Human Vaccine Value Chain Analysis
8.1.1 Human Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Human Vaccine Production Mode & Process
8.2 Human Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Human Vaccine Distributors
8.2.3 Human Vaccine Customers
9 GLOBAL HUMAN VACCINE ANALYZING MARKET DYNAMICS
9.1 Human Vaccine Industry Trends
9.2 Human Vaccine Industry Drivers
9.3 Human Vaccine Industry Opportunities and Challenges
9.4 Human Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Human Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Human Vaccine Sales (2019-2030)
2.2.3 Global Human Vaccine Market Average Price (2019-2030)
2.3 Human Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
2.4 Human Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Adults
2.4.3 Children
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Human Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Human Vaccine Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Human Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Human Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Human Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Human Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Human Vaccine, Product Type & Application
3.8 Global Manufacturers of Human Vaccine, Date of Enter into This Industry
3.9 Global Human Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 CNBG
4.1.1 CNBG Company Information
4.1.2 CNBG Business Overview
4.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 CNBG Human Vaccine Product Portfolio
4.1.5 CNBG Recent Developments
4.2 Changsheng Life
4.2.1 Changsheng Life Company Information
4.2.2 Changsheng Life Business Overview
4.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Changsheng Life Human Vaccine Product Portfolio
4.2.5 Changsheng Life Recent Developments
4.3 Zhifei
4.3.1 Zhifei Company Information
4.3.2 Zhifei Business Overview
4.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Zhifei Human Vaccine Product Portfolio
4.3.5 Zhifei Recent Developments
4.4 ChengDa Bio
4.4.1 ChengDa Bio Company Information
4.4.2 ChengDa Bio Business Overview
4.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 ChengDa Bio Human Vaccine Product Portfolio
4.4.5 ChengDa Bio Recent Developments
4.5 Kangtai
4.5.1 Kangtai Company Information
4.5.2 Kangtai Business Overview
4.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Kangtai Human Vaccine Product Portfolio
4.5.5 Kangtai Recent Developments
4.6 SINOVAC BIOTECH
4.6.1 SINOVAC BIOTECH Company Information
4.6.2 SINOVAC BIOTECH Business Overview
4.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 SINOVAC BIOTECH Human Vaccine Product Portfolio
4.6.5 SINOVAC BIOTECH Recent Developments
4.7 Hissen
4.7.1 Hissen Company Information
4.7.2 Hissen Business Overview
4.7.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Hissen Human Vaccine Product Portfolio
4.7.5 Hissen Recent Developments
4.8 Walvax Biotechnology
4.8.1 Walvax Biotechnology Company Information
4.8.2 Walvax Biotechnology Business Overview
4.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Walvax Biotechnology Human Vaccine Product Portfolio
4.8.5 Walvax Biotechnology Recent Developments
4.9 GSK
4.9.1 GSK Company Information
4.9.2 GSK Business Overview
4.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.9.4 GSK Human Vaccine Product Portfolio
4.9.5 GSK Recent Developments
4.10 SANOFI
4.10.1 SANOFI Company Information
4.10.2 SANOFI Business Overview
4.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.10.4 SANOFI Human Vaccine Product Portfolio
4.10.5 SANOFI Recent Developments
6.11 Rong An
6.11.1 Rong An Company Information
6.11.2 Rong An Human Vaccine Business Overview
6.11.3 Rong An Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Rong An Human Vaccine Product Portfolio
6.11.5 Rong An Recent Developments
6.12 NuoCheng Bio
6.12.1 NuoCheng Bio Company Information
6.12.2 NuoCheng Bio Human Vaccine Business Overview
6.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 NuoCheng Bio Human Vaccine Product Portfolio
6.12.5 NuoCheng Bio Recent Developments
6.13 Hualan Bio
6.13.1 Hualan Bio Company Information
6.13.2 Hualan Bio Human Vaccine Business Overview
6.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hualan Bio Human Vaccine Product Portfolio
6.13.5 Hualan Bio Recent Developments
6.14 Tiantan biological
6.14.1 Tiantan biological Company Information
6.14.2 Tiantan biological Human Vaccine Business Overview
6.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Tiantan biological Human Vaccine Product Portfolio
6.14.5 Tiantan biological Recent Developments
6.15 Changchun Baike
6.15.1 Changchun Baike Company Information
6.15.2 Changchun Baike Human Vaccine Business Overview
6.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Changchun Baike Human Vaccine Product Portfolio
6.15.5 Changchun Baike Recent Developments
6.16 Adimmune
6.16.1 Adimmune Company Information
6.16.2 Adimmune Human Vaccine Business Overview
6.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Adimmune Human Vaccine Product Portfolio
6.16.5 Adimmune Recent Developments
6.17 Zhongyianke Biotech
6.17.1 Zhongyianke Biotech Company Information
6.17.2 Zhongyianke Biotech Human Vaccine Business Overview
6.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Zhongyianke Biotech Human Vaccine Product Portfolio
6.17.5 Zhongyianke Biotech Recent Developments
6.18 Bharat Biotech
6.18.1 Bharat Biotech Company Information
6.18.2 Bharat Biotech Human Vaccine Business Overview
6.18.3 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Bharat Biotech Human Vaccine Product Portfolio
6.18.5 Bharat Biotech Recent Developments
6.19 Bavarian Nordic
6.19.1 Bavarian Nordic Company Information
6.19.2 Bavarian Nordic Human Vaccine Business Overview
6.19.3 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Bavarian Nordic Human Vaccine Product Portfolio
6.19.5 Bavarian Nordic Recent Developments
6.20 Sanofi-Pasteur
6.20.1 Sanofi-Pasteur Company Information
6.20.2 Sanofi-Pasteur Human Vaccine Business Overview
6.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Sanofi-Pasteur Human Vaccine Product Portfolio
6.20.5 Sanofi-Pasteur Recent Developments
6.21 Indian Immunologicals
6.21.1 Indian Immunologicals Company Information
6.21.2 Indian Immunologicals Human Vaccine Business Overview
6.21.3 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Indian Immunologicals Human Vaccine Product Portfolio
6.21.5 Indian Immunologicals Recent Developments
6.22 KANGH
6.22.1 KANGH Company Information
6.22.2 KANGH Human Vaccine Business Overview
6.22.3 KANGH Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.22.4 KANGH Human Vaccine Product Portfolio
6.22.5 KANGH Recent Developments
6.23 Henan Grand Biopharma
6.23.1 Henan Grand Biopharma Company Information
6.23.2 Henan Grand Biopharma Human Vaccine Business Overview
6.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Henan Grand Biopharma Human Vaccine Product Portfolio
6.23.5 Henan Grand Biopharma Recent Developments
6.24 ZhongKe Biopharm
6.24.1 ZhongKe Biopharm Company Information
6.24.2 ZhongKe Biopharm Human Vaccine Business Overview
6.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.24.4 ZhongKe Biopharm Human Vaccine Product Portfolio
6.24.5 ZhongKe Biopharm Recent Developments
6.25 Zhuoyi Biological
6.25.1 Zhuoyi Biological Company Information
6.25.2 Zhuoyi Biological Human Vaccine Business Overview
6.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Zhuoyi Biological Human Vaccine Product Portfolio
6.25.5 Zhuoyi Biological Recent Developments
5 GLOBAL HUMAN VACCINE MARKET SCENARIO BY REGION
5.1 Global Human Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Human Vaccine Sales by Region: 2019-2030
5.2.1 Global Human Vaccine Sales by Region: 2019-2024
5.2.2 Global Human Vaccine Sales by Region: 2025-2030
5.3 Global Human Vaccine Revenue by Region: 2019-2030
5.3.1 Global Human Vaccine Revenue by Region: 2019-2024
5.3.2 Global Human Vaccine Revenue by Region: 2025-2030
5.4 North America Human Vaccine Market Facts & Figures by Country
5.4.1 North America Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Human Vaccine Sales by Country (2019-2030)
5.4.3 North America Human Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Human Vaccine Market Facts & Figures by Country
5.5.1 Europe Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Human Vaccine Sales by Country (2019-2030)
5.5.3 Europe Human Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Human Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Human Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Human Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Human Vaccine Market Facts & Figures by Country
5.7.1 Latin America Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Human Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Human Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Human Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Human Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Human Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Human Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Human Vaccine Sales by Type (2019-2030)
6.1.1 Global Human Vaccine Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Human Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Human Vaccine Revenue by Type (2019-2030)
6.2.1 Global Human Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Human Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Human Vaccine Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Human Vaccine Sales by Application (2019-2030)
7.1.1 Global Human Vaccine Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Human Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Human Vaccine Revenue by Application (2019-2030)
6.2.1 Global Human Vaccine Sales by Application (2019-2030) & (US$ Million)
6.2.2 Global Human Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Human Vaccine Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Human Vaccine Value Chain Analysis
8.1.1 Human Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Human Vaccine Production Mode & Process
8.2 Human Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Human Vaccine Distributors
8.2.3 Human Vaccine Customers
9 GLOBAL HUMAN VACCINE ANALYZING MARKET DYNAMICS
9.1 Human Vaccine Industry Trends
9.2 Human Vaccine Industry Drivers
9.3 Human Vaccine Industry Opportunities and Challenges
9.4 Human Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
